RNA Reference Standards & Controls Market
完整報告名稱與涵蓋範圍
RNA Reference Standards & Controls Market Size, Share & Trends Analysis Report, By Product Type (mRNA and Long RNA Reference Materials, Synthetic RNA Controls and Calibrators for Diagnostics, Certified Reference Materials and System Suitability Standards, Custom and Program-Specific Standards), By Application (mRNA Therapeutics and Vaccine Quality Control, Molecular Diagnostics and Assay Development, Sequencing and Research Standardization), By Grade (Research Grade, ISO 17034 and GMP-Aligned Grades), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The RNA reference standards and controls market covers characterised RNA materials used to calibrate, validate and monitor analytical methods and diagnostic assays, including mRNA and long RNA reference materials for therapeutic quality control, synthetic RNA controls and calibrators for molecular diagnostics, certified and system suitability standards and custom program-specific standards. General research reagents and RNA extraction kits are excluded.
Demand is rising on two fronts: therapeutic mRNA manufacturers need well-characterised standards to validate integrity, capping, tail and potency methods and to demonstrate comparability across sites and process changes, while diagnostic developers and clinical laboratories require stable RNA controls for viral load, oncology and infectious disease assays, a need that pandemic testing made permanent. Standards bodies and consortia are developing certified materials and interlaboratory studies to harmonise mRNA measurement, and suppliers are producing encapsulated, lyophilised and multiplex controls with defined copy numbers. Regulatory emphasis on method validation and the shift to multi-attribute analytics increase the number and sophistication of standards required.
North America and Europe dominate supply and consumption, with Asia Pacific demand growing alongside diagnostic manufacturing and RNA therapeutics in China, Japan and South Korea. Competition involves nucleic acid manufacturers, reference material specialists, diagnostic control suppliers and national metrology institutes.
The InsightAce study supplies US$ forecasts for all product type, application, grade and end user and regional segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global RNA Reference Standards & Controls Market Snapshot
Chapter 4. Global RNA Reference Standards & Controls Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. Product Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product Type:
5.2.1. mRNA and Long RNA Reference Materials
5.2.2. Synthetic RNA Controls and Calibrators for Diagnostics
5.2.3. Certified Reference Materials and System Suitability Standards
5.2.4. Custom and Program-Specific Standards
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. Application & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
6.2.1. mRNA Therapeutics and Vaccine Quality Control
6.2.2. Molecular Diagnostics and Assay Development
6.2.3. Sequencing and Research Standardization
Chapter 7. Market Segmentation 3: By Grade Estimates & Trend Analysis
7.1. Grade & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Grade:
7.2.1. Research Grade
7.2.2. ISO 17034 and GMP-Aligned Grades
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Pharmaceutical and Biotechnology Companies
8.2.2. Diagnostic Manufacturers and Clinical Laboratories
8.2.3. Academic, Government and Standards Bodies
Chapter 9. RNA Reference Standards & Controls Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. TriLink BioTechnologies (Maravai LifeSciences)
11.2. Thermo Fisher Scientific Inc.
11.3. Twist Bioscience Corporation
11.4. LGC Limited
11.5. Revvity, Inc. (Horizon Discovery)
11.6. Bio-Rad Laboratories, Inc.
11.7. Seracare (LGC Clinical Diagnostics)
11.8. Exact Diagnostics (Bio-Rad)
11.9. Microbiologics, Inc.
11.10. ATCC
11.11. National Institute of Standards and Technology (NIST)
11.12. Qiagen N.V.
11.13. Integrated DNA Technologies, Inc. (Danaher)
11.14. Merck KGaA (MilliporeSigma)
11.15. Roche CustomBiotech
圖表清單 List of Tables & Figures
Table 1. Global RNA Reference Standards & Controls Revenue Forecast by Product Type, 2026-2035 (US$ Mn)
Figure 1. Global RNA Reference Standards & Controls Market Snapshot, 2026 & 2035
Table 2. Global RNA Reference Standards & Controls Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 2. Global RNA Reference Standards & Controls Market Share by Application, 2026 & 2035
Table 3. Global RNA Reference Standards & Controls Revenue Forecast by Grade, 2026-2035 (US$ Mn)
Figure 3. RNA Reference Material Requirements Across Therapeutic Quality Control and Diagnostic Assays
Table 4. Global RNA Reference Standards & Controls Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Certified Reference Material Development and Interlaboratory Harmonisation Initiatives
Table 5. North America RNA Reference Standards & Controls Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific RNA Reference Standards & Controls Growth Opportunity Analysis
Table 6. Europe RNA Reference Standards & Controls Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Control Format Innovation: Encapsulated, Lyophilised and Multiplex RNA Controls
Table 7. Asia Pacific RNA Reference Standards & Controls Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Competitive Positioning of Key RNA Reference Standards & Controls Market Participants
Table 8. Latin America and Middle East & Africa RNA Reference Standards & Controls Revenue Forecast, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們